Publications

 2016

 

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin
J Diabetes Sci Technolo.  2016
View Publication

The Need for Faster Insulin: Problem Solved?
J Diabetes Sci Technolo.  2016
View Publication

PK and PD properties of a Novel Inhaled insulin
J Diabetes Sci Technolo.  2016
View Publication

Improving efficacy of inhaled TI (Afrezza) by postmeal dosing:  In silico clinical trial with the University of Virginia/Padova Type 1 Diabetes Simulator
Diabetes Technol Ther. 2016
View Publication

Technosphere® Insulin Inhalation Powder (TI) Displays Earlier Onset and Shorter Duration than Insulin Lispro (Lispro)
ADA 2016, poster 100-LB
View Publication

Within-Subject Variability of Insulin Exposure and Metabolic Activity Following Replicate Doses of Technosphere® Insulin Inhalation Powder (TI) in Patients with T1DM
ADA 2016, poster 102-LB
View Publication

Effects of Inhaled Technosphere Insulin (TI) on the Pulmonary Function of Patients with T1D and T2D
ADA 2016, poster 937-P
View Publication

The Impact of Baseline Lung Function on Outcomes With Inhaled Technosphere Insulin
ADA 2016, poster 973-P
View Publication

Technosphere® Inhaled Human Insulin has a More Rapid Onset of Action Than Subcutaneous Insulins – Meta Analysis of Clamp Data From Three Clinical Studies
ADA 2016, poster 931-P
View Publication

A Population PK/PD Model of Technosphere® Insulin Administered to Healthy Subjects
ADA 2016, poster 975-P
View Publication

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere® Inhaled Insulin
BMJ Open Diabetes Research and Car 2016; 4:e000228
View Publication

Impact of Upper Respiratory Tract Infection on the Safety of Technosphere® Inhaled Insulin in Patients with Type 1 or Type 2 Diabetes
AACE 2016
View Publication

 

 

 

2015

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
Diabetes Care 2015 Dec.  38(12):2274-81
View Publication

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
Diabetes Care 2015 Dec.  38(12):2266-73
View Publication

Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation
AAPS PharmSciTech, 2015 Dec.  16(6):1299-306
View Publication

Reduced Hypoglycemia is Observed with Inhaled Insulin Versus Subcutaneous Insulin Aspart in Patients with Type 1 Diabetes Mellitus
AACE 2015, poster 1220
View Publication

Patient Level Assessment of Cough with TI in Patients with T1DM
Diabetes Technology Meeting 2015
View Publication

Inhalation of Insulin: Effect of Symptomatic Upper Respiratory Tract Infections on Pharmacokinetic/Pharmacodynamic (PK/PD) Properties
ADA 2015, Poster 94-LB
View Publication

Reduced Hypoglycaemia is observed with Inhaled Insulin Versus Subcutaneous Insulin Aspart in Patients with Type 1 Diabetes Mellitus
EASD 2015
View Publication

2013

A Phase 1, Open-Label, Randomized Dose Proportionality Study of Technosphere Insulin Inhalation
ADA 2013, Poster 982-P
View Publication

Device factors affecting pulmonary delivery of dry powders.
Ther Deliv 2013 Aug;4(8): 939-49
View Publication

 

2012

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere® Insulin or usual antidiabetes treatment: A randomized trial.
Diabetes, Obesity and Metabolism 2012;14:163-173
View Publication

Technosphere® insulin effectively controls postprandial glycemia in patients with T2 Diabetes Mellitus.
Diabetes Technology and Therapeutics 2012;14:997-1001
View Publication

WARNING:


If you are reporting an Adverse Event and/or device complaint, please contact MannKind Medical Information at 1-877-323-8505 or MannKind@druginfo.com. Do not use this form for adverse events and/or device complaints.

Close